SPOTLIGHT: CDC: Recalled drug sickens 50

In the wake of Baxter's recall of several batches of its heparin blood thinner, the Centers for Disease Control and Prevention has announced that more than 50 dialysis patients in 12 states have had allergic reactions, probably due to the drug. Report

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.